204 related articles for article (PubMed ID: 37504318)
1. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
Al-Ezzi EM; Zahralliyali A; Hansen AR; Hamilton RJ; Crump M; Kuruvilla J; Wood L; Nappi L; Kollmannsberger CK; North SA; Winquist E; Soulières D; Hotte SJ; Jiang DM
Curr Oncol; 2023 Jun; 30(7):6166-6176. PubMed ID: 37504318
[TBL] [Abstract][Full Text] [Related]
2. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy for relapsed testicular germ cell tumours.
Chovanec M; Adra N; Abu Zaid M; Abonour R; Einhorn L
Nat Rev Urol; 2023 Apr; 20(4):217-225. PubMed ID: 36477219
[TBL] [Abstract][Full Text] [Related]
4. Salvage high-dose chemotherapy for germ cell tumors.
Feldman DR; Powles T
Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
Selle F; Wittnebel S; Biron P; Gravis G; Roubaud G; Bui BN; Delva R; Bay JO; Fléchon A; Geoffrois L; Caty A; Soares DG; de Revel T; Fizazi K; Gligorov J; Micléa JM; Dubot C; Provent S; Temby I; Gaulet M; Horn E; Brindel I; Lotz JP
Ann Oncol; 2014 Sep; 25(9):1775-1782. PubMed ID: 24894084
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
Connolly EA; Weickhardt A; Grimison P; Asher R; Heller GZ; Lewin J; Liow E; Toner G; Tung ILY; Tran B; Hill S; Walpole E; McKenzie J; Kuchel A; Goh J; Forgeson G; Tan A; Joshi A; Wickham A; Tan H; Wang Y; Winstanley MA; Hamad N; Wong V
BJU Int; 2022 Jun; 130 Suppl 1():5-16. PubMed ID: 35355402
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
Rashid S; Lim L; Powles T
Curr Treat Options Oncol; 2012 Jun; 13(2):201-11. PubMed ID: 22623055
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers.
Villela NC; Seber A; Macedo CRPD; Zecchin VG; Guimarães RFDC; Faria TMV; Vidal DO; Jorge GEM; Navarro G; Lopes LF
Pediatr Hematol Oncol; 2023; 40(6):539-553. PubMed ID: 36940088
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
11. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M
Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
[TBL] [Abstract][Full Text] [Related]
13. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study.
Ferhatoglu F; Paksoy N; Khanmammadov N; Yildiz A; Ahmed MA; Gülbas Z; Basaran M
Medicine (Baltimore); 2024 Feb; 103(8):e37213. PubMed ID: 38394499
[TBL] [Abstract][Full Text] [Related]
15. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
[TBL] [Abstract][Full Text] [Related]
16. Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
De Pasquale MD; D'Angelo P; Crocoli A; Boldrini R; Conte M; Bisogno G; Spreafico F; Inserra A; Biasoni D; Dall'Igna P; Siracusa F; Miele E; Terenziani M
Pediatr Blood Cancer; 2020 Mar; 67(3):e28125. PubMed ID: 31850649
[TBL] [Abstract][Full Text] [Related]
17. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L
Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392
[TBL] [Abstract][Full Text] [Related]
19. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
[TBL] [Abstract][Full Text] [Related]
20. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Lorch A; Kollmannsberger C; Hartmann JT; Metzner B; Schmidt-Wolf IG; Berdel WE; Weissinger F; Schleicher J; Egerer G; Haas A; Schirren R; Beyer J; Bokemeyer C; Rick O;
J Clin Oncol; 2007 Jul; 25(19):2778-84. PubMed ID: 17602082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
